Dosing and Administration of GSK3β Inhibitors in Mice to Support SYNGAP1 Research

• Principal Investigator: Sarina Mohanty, PhD
• Institution: 4M Therapeutics
• Grant Number: 2024.9
• Funding Amount: $120,000.00
• Percentage Dispersed: 100%
• Grant Status: Signed & Active

You can find 4M’s press release here.